Effect of Incidental Findings Information on Lung Cancer Screening Intent

NCT04432753 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 419

Last updated 2020-12-10

No results posted yet for this study

Summary

This online randomized controlled trial seeks to determine if inclusion of incidental findings information in a lung cancer screening decision aid affects screening intent among screening-eligible individuals. Participants will view either a decision aid with incidental findings information or without and indicate their intent to pursue lung cancer screening.

Hypothesis: Inclusion of incidental findings in a decision aid will decrease intent to screen among participants.

Conditions

  • Neoplasm of Lung
  • Decision Support Techniques
  • Mass Screening

Interventions

BEHAVIORAL

Lung Cancer Screening Decision Aid with Incidental Findings Information

The intervention consists of a previously tested and developed brief lung cancer screening video decision aid with the addition of information on incidental findings for lung cancer screening.

BEHAVIORAL

Lung Cancer Screening Decision Aid without Incidental Findings Information

The intervention consists of a previously tested and developed brief lung cancer screening video decision aid that does not include information on incidental findings.

Sponsors & Collaborators

  • UNC Cecil G. Sheps Center for Health Services Research

    collaborator UNKNOWN
  • UNC Lineberger Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Stephen Clark, MD · University of North Carolina, Chapel Hill

  • Daniel Jonas, MD, MPH · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-16
Primary Completion
2020-08-22
Completion
2020-08-22

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04432753 on ClinicalTrials.gov